These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
650 related articles for article (PubMed ID: 19153092)
1. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone. Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092 [TBL] [Abstract][Full Text] [Related]
2. Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Lie Fong S; Lugtenburg PJ; Schipper I; Themmen AP; de Jong FH; Sonneveld P; Laven JS Hum Reprod; 2008 Mar; 23(3):674-8. PubMed ID: 18216040 [TBL] [Abstract][Full Text] [Related]
3. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors. Lunsford AJ; Whelan K; McCormick K; McLaren JF Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876 [TBL] [Abstract][Full Text] [Related]
4. Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Mulders AG; Laven JS; Eijkemans MJ; de Jong FH; Themmen AP; Fauser BC Hum Reprod; 2004 Sep; 19(9):2036-42. PubMed ID: 15217995 [TBL] [Abstract][Full Text] [Related]
5. [Anti-mullerian hormone in young women after chemotherapy and infradiaphragmatic radiotherapy for childhood cancer]. Krawczuk-Rybak M; Leszczyńska E; Wysocka J; Zelazowska-Rutkowska B Pediatr Endocrinol Diabetes Metab; 2008; 14(2):99-103. PubMed ID: 18721496 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal follow-up in female Childhood Cancer Survivors: no signs of accelerated ovarian function loss. van der Kooi AL; van den Heuvel-Eibrink MM; van Noortwijk A; Neggers SJ; Pluijm SM; van Dulmen-den Broeder E; van Dorp W; Laven JS Hum Reprod; 2017 Jan; 32(1):193-200. PubMed ID: 27821706 [TBL] [Abstract][Full Text] [Related]
7. Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus. Soto N; Iñiguez G; López P; Larenas G; Mujica V; Rey RA; Codner E Hum Reprod; 2009 Nov; 24(11):2838-44. PubMed ID: 19643804 [TBL] [Abstract][Full Text] [Related]
8. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). La Marca A; Sighinolfi G; Radi D; Argento C; Baraldi E; Artenisio AC; Stabile G; Volpe A Hum Reprod Update; 2010; 16(2):113-30. PubMed ID: 19793843 [TBL] [Abstract][Full Text] [Related]
9. Anti-mullerian hormone as a marker of ovarian reserve. Tremellen KP; Kolo M; Gilmore A; Lekamge DN Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):20-4. PubMed ID: 15730360 [TBL] [Abstract][Full Text] [Related]
11. A 10-year follow up of reproductive function in women treated for childhood cancer. Nielsen SN; Andersen AN; Schmidt KT; Rechnitzer C; Schmiegelow K; Bentzen JG; Larsen EC Reprod Biomed Online; 2013 Aug; 27(2):192-200. PubMed ID: 23768622 [TBL] [Abstract][Full Text] [Related]
12. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. van Casteren NJ; van der Linden GH; Hakvoort-Cammel FG; Hählen K; Dohle GR; van den Heuvel-Eibrink MM Pediatr Blood Cancer; 2009 Jan; 52(1):108-12. PubMed ID: 18819129 [TBL] [Abstract][Full Text] [Related]
13. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia. Iwase A; Sugita A; Hirokawa W; Goto M; Yamamoto E; Takikawa S; Nakahara T; Nakamura T; Kondo M; Kikkawa F Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):194-8. PubMed ID: 23274042 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure. Massin N; Méduri G; Bachelot A; Misrahi M; Kuttenn F; Touraine P Mol Cell Endocrinol; 2008 Jan; 282(1-2):95-100. PubMed ID: 18191888 [TBL] [Abstract][Full Text] [Related]
15. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy. Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632 [TBL] [Abstract][Full Text] [Related]
16. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Gnoth C; Schuring AN; Friol K; Tigges J; Mallmann P; Godehardt E Hum Reprod; 2008 Jun; 23(6):1359-65. PubMed ID: 18387961 [TBL] [Abstract][Full Text] [Related]
17. Hormone and Sperm Analyses after Chemo- and Radiotherapy in Childhood and Adolescence. Rendtorff R; Hohmann C; Reinmuth S; Müller A; Dittrich R; Beyer M; Wickmann L; Keil T; Henze G; Borgmann-Staudt A Klin Padiatr; 2010 May; 222(3):145-9. PubMed ID: 20514617 [TBL] [Abstract][Full Text] [Related]
18. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Partridge AH; Ruddy KJ; Gelber S; Schapira L; Abusief M; Meyer M; Ginsburg E Fertil Steril; 2010 Jul; 94(2):638-44. PubMed ID: 19409543 [TBL] [Abstract][Full Text] [Related]
19. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Lee TH; Liu CH; Huang CC; Wu YL; Shih YT; Ho HN; Yang YS; Lee MS Hum Reprod; 2008 Jan; 23(1):160-7. PubMed ID: 18000172 [TBL] [Abstract][Full Text] [Related]